Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)
NCT02568722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3019
Last updated 2024-10-18
Summary
The objectives of this trial are to determine whether, in critically ill patients with severe acute kidney injury (AKI), randomization to accelerated initiation of renal replacement therapy (RRT), compared to standard initiation, leads to:
1. Improved survival (primary outcome); and
2. Recovery of kidney function (principal secondary outcome), defined as independence from RRT at 90 days
Conditions
Interventions
- OTHER
-
Standard RRT initiation
In the absence of kidney function recovery, the initiation of RRT will be permitted if one of the following develops: serum potassium ≥ 6.0 mmol/L; pH ≤ 7.20 or serum bicarbonate ≤ 12 mmol/L; evidence of severe respiratory failure, based on a PaO2/FiO2 ≤ 200 and clinical perception of volume overload; and/or persistent AKI \> 72 hours following the time of randomization.
- OTHER
-
Accelerated RRT initiation
A dialysis catheter will be placed and RRT initiated as soon as possible and within 12 hours of eligibility. This 12 hour window includes the time needed to obtain consent.
Sponsors & Collaborators
-
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
National Health and Medical Research Council, Australia
collaborator OTHER -
Baxter Healthcare Corporation
collaborator INDUSTRY -
The George Institute
collaborator OTHER -
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
Medical Research Institute of New Zealand
collaborator OTHER -
Health Research Council, New Zealand
collaborator OTHER -
Unity Health Toronto
lead OTHER
Principal Investigators
-
Ron Wald, MDCM MPH · Unity Health Toronto
-
Sean M Bagshaw, MD MSc · University of Alberta
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
- Australia
- Austria
- Belgium
- Brazil
- Canada
- China
- Finland
- France
- Germany
- Ireland
- Italy
- New Zealand
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions
NCT04505891 ·Status: COMPLETED ·Phase: NA
-
A Clinical Model for Dialysis Discontinuation in AKI
NCT06005896 ·Status: COMPLETED
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NCT05758077 ·Status: RECRUITING ·Phase: NA
-
Predictive Score for the Success of Discontinuation of Renal Replacement Therapy (RRT) in Intensive Care
NCT07317362 ·Status: COMPLETED
-
Nutritional Therapy to Prevent Progression of Acute Kidney Injury to Chronic Kidney Disease
NCT02831062 ·Status: COMPLETED ·Phase: NA
-
A Study of Acute Kidney Injury in Care Transitions
NCT05184894 ·Status: COMPLETED ·Phase: NA
-
Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis
NCT04948476 ·Status: COMPLETED ·Phase: NA
-
Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator
NCT06696235 ·Status: RECRUITING ·Phase: PHASE4
-
Outcomes of Critically Ill Patients Undergoing RRT- a Registry Based Study.
NCT06897254 ·Status: COMPLETED
-
Early RRT in AKI After Cardiac Surgery
NCT05175053 ·Status: TERMINATED ·Phase: NA
-
Standard Versus Comprehensive Care for Post Acute Kidney Injury
NCT04012008 ·Status: COMPLETED ·Phase: NA
-
Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT ( KETZEREI )
NCT06021288 ·Status: RECRUITING ·Phase: NA
-
CRRT Timing in Sepsis-associated AKI in ICU
NCT03175328 ·Status: UNKNOWN ·Phase: NA
-
A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury
NCT02687841 ·Status: UNKNOWN ·Phase: PHASE3
-
Augmented Vs. Normal Renal Replacement Therapy in Severe Acute Renal Failure (ARF).
NCT00221013 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Kidney Injury Predictor Validation Study
NCT03574896 ·Status: COMPLETED
-
Filter Lifespan in Continuous Renal Replacement Therapy
NCT05450185 ·Status: RECRUITING
-
Albumin To Enhance Recovery After Acute Kidney Injury
NCT04705896 ·Status: RECRUITING ·Phase: PHASE4
-
REVERSE-AKI Randomized Controlled Pilot Trial
NCT03251131 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Different Anticoagulants for Renal Replacement Therapy
NCT02669589 ·Status: COMPLETED ·Phase: PHASE4
-
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
NCT05468203 ·Status: TERMINATED ·Phase: PHASE3
-
IHD Versus CRRT for Severe Acute Kidney Injury in Critically Ill Patients
NCT06032884 ·Status: RECRUITING ·Phase: NA
-
CRRTNet Registry- A Prospective Observational Registry
NCT02034448 ·Status: UNKNOWN
-
Prospective Validation of AKI Prediction
NCT06804200 ·Status: RECRUITING
-
Multidiscipline Care for Acute Kidney Disease (AKD)
NCT05064904 ·Status: UNKNOWN ·Phase: NA